机器人辅助单孔腹腔镜手术在妇科肿瘤领域的可行性
本研究回顾性分析2014至2016年同一妇科肿瘤医生为高度选择的患者实施的30例机器人辅助单孔腹腔镜(R-LESS)子宫切除术,适应证包括子宫癌、宫颈癌前病变或子宫癌前病变、宫颈癌及遗传性妇科肿瘤风险;结论认为R-LESS筋膜外及根治性子宫切除术的手术时间和围手术期结局可接受,随着经验积累可扩展至更复杂手术。
要点
- 30例R-LESS子宫切除术中位手术时间140分钟(范围115-179),无围手术期并发症,均于术后24小时内出院。
- 14例同时行盆腔前哨淋巴结示踪中位手术时间175分钟,2例同时行盆腔淋巴结清扫中位手术时间233分钟。
- 3例根治性子宫切除术中位手术时间412分钟(范围336-451)。
核心结论
- 在高度选择的患者中,R-LESS筋膜外及根治性子宫切除术的手术时间和围手术期结局可接受;随着经验积累,外科医生可为接受日益复杂手术的患者提供此方法,即使在妇科肿瘤领域也是如此。
研究设计与样本
- 回顾性研究(加拿大任务组分类II-3),在学术性大学医院开展,纳入2014至2016年间由同一妇科肿瘤医生为妇科恶性肿瘤、浸润前病变或风险降低而接受R-LESS子宫切除术的患者,共30例。
主要发现
- 手术指征包括子宫癌13例、宫颈或子宫浸润前病变9例、宫颈癌3例、遗传性妇科肿瘤风险5例;患者中位年龄52岁(范围35-77),中位体重指数26 kg/m2(范围19-34),中位子宫大小8 cm(范围5.5-11),18例(60%)有腹部手术史。
- 27例接受R-LESS筋膜外子宫切除术,其中11例仅行机器人辅助全腹腔镜子宫切除术±双侧输卵管卵巢切除术,中位手术时间140分钟(范围115-179);其余患者同时行盆腔前哨淋巴结示踪14例(中位手术时间175分钟,范围150-230)和盆腔淋巴结清扫2例(中位手术时间233分钟)。
- 1例子宫内膜癌患者因冰冻切片提示高风险疾病而中转多孔机器人手术以完成盆腔及腹主动脉旁淋巴结清扫;3例接受R-LESS根治性子宫切除术、双侧输卵管卵巢切除术、前哨淋巴结示踪及盆腔淋巴结清扫,中位手术时间412分钟(范围336-451)。
- 无围手术期并发症,所有患者均在术后24小时内出院。
临床怎么用
- 作者认为,在高度选择的患者中,R-LESS筋膜外及根治性子宫切除术与可接受的手术时间和围手术期结局相关;随着经验积累,外科医生可为接受日益复杂手术的患者提供此方法,即使在妇科肿瘤领域也是如此。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To assess the feasibility of incorporating robotic laparoendoscopic single-site (R-LESS) surgery into gynecologic oncology care. DESIGN: Retrospective study (Canadian Task Force classification II-3). SETTING: Academic university hospital. PATIENTS: Patients undergoing R-LESS hysterectomy for gynecologic malignancies, preinvasive disease, or risk reduction performed by a single gynecologic oncologist between 2014 and 2016. INTERVENTIONS: We incorporated R-LESS as part of standard surgical management for highly selected patients undergoing hysterectomy for common gynecologic oncology indications. MEASUREMENTS AND MAIN RESULTS: We identified 30 patients undergoing R-LESS hysterectomy meeting study criteria over a 2-year period. Indications for surgery included uterine cancer (n = 13), preinvasive cervical or uterine disease (n = 9), cervical cancer (n = 3), and hereditary gynecologic cancer risk (n = 5). Median patient age was 52 years (range, 35-77), and body mass index was 26 kg/m2 (range, 19-34). Median uterine size was 8 cm (range, 5.5-11). Eighteen patients had prior abdominal surgery (60%). Twenty-seven patients underwent R-LESS extrafascial hysterectomy, 11 of whom underwent only robotic-assisted total laparoscopic hysterectomy ± bilateral salpingo-oophorectomy with a median operative time of 140 minutes (range, 115-179). Procedures performed concurrently for the remainder included pelvic sentinel lymph node mapping (n = 14) and pelvic lymphadenectomy (n = 2), with respective median operative times of 175 (range, 150-230) and 233 minutes. One patient with endometrial cancer was converted to multiport robotic surgery to complete a pelvic and para-aortic lymphadenectomy due to high-risk disease on frozen section. Three patients underwent R-LESS radical hysterectomy, bilateral salpingo-oophorectomy, sentinel lymph node mapping, and pelvic lymphadenectomy with a median operative time of 412 minutes (range, 336-451). No perioperative complications were encountered, and all patients were discharged within 24 hours of surgery. CONCLUSION: In highly selected patients, R-LESS extrafascial and radical hysterectomy is associated with acceptable operative times and perioperative outcomes. With additional experience, surgeons may offer this approach to patients undergoing increasingly complex procedures, even in the gynecologic oncology setting.
引用
- Moukarzel LA, Fader AN, Tanner EJ, et al. Feasibility of Robotic-Assisted Laparoendoscopic Single-Site Surgery in the Gynecologic Oncology Setting. J Minim Invasive Gynecol. 2016. PMID: 27815041. doi:10.1016/j.jmig.2016.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。